Cloverfields Capital Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$8.1M |
| 2 |
Shattuck Labs
STTK
|
+$1.89M |
| 3 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$1.81M |
| 4 |
Walt Disney
DIS
|
+$1.65M |
| 5 |
GE Aerospace
GE
|
+$1.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Frontdoor
FTDR
|
+$1.1M |
| 2 |
Ferrari
RACE
|
+$771K |
| 3 |
O'Reilly Automotive
ORLY
|
+$718K |
| 4 |
NetEase
NTES
|
+$123K |
| 5 |
Idexx Laboratories
IDXX
|
+$98.2K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 76.42% |
| 2 | Technology | 6.52% |
| 3 | Consumer Discretionary | 4.87% |
| 4 | Financials | 3.45% |
| 5 | Industrials | 3.16% |
Similar funds
Cloverfields Capital Group's Q1 2021 Portfolio in Review
As of Q1 2021, Cloverfields Capital Group held 63 positions worth $309M, up 16% from $266M the previous quarter. Its ten largest holdings account for 81% of the portfolio.
Cloverfields Capital Group deployed $27.3M of net new capital in Q1 2021, opening 7 new positions and adding to 49 existing holdings. Its largest new stake was Shattuck Labs: 45,000 shares worth $1.32M.
By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 80% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NetEase, an estimated $123K trimmed.
- Cloverfields Capital Group's largest Q1 2021 buy was Shattuck Labs: 45,000 shares worth $1.32M.
- Cloverfields Capital Group added most to UnitedHealth in Q1 2021, an estimated $8.1M increase.
- Cloverfields Capital Group's biggest Q1 2021 reduction was NetEase, cutting an estimated $123K.
- Cloverfields Capital Group fully exited Frontdoor in Q1 2021, selling an estimated $1.1M.
- Cloverfields Capital Group's ten largest holdings make up 81% of its $309M portfolio in Q1 2021.
- Cloverfields Capital Group opened 7 new positions and closed 4 in Q1 2021.
- Cloverfields Capital Group's portfolio value rose 16% quarter-over-quarter to $309M.
Based on Cloverfields Capital Group's 13F filing for Q1 2021, filed 13 May 2021.